The American Society of Clinical Oncology (ASCO) released a detailed analysis of the Centers for Medicare & Medicaid Services' Medicare Physician Fee Schedule proposed rule for 2024. ASCO's analysis looks at how specialty, location, and other factors would impact physician reimbursement under the proposal.
ASCO in Action provides the latest news and analysis related to critical policy issues affecting the cancer community, updates on the Association for Clinical Oncology’s ongoing advocacy efforts, and opportunities for members and others in the cancer care community to take action.
To sign up for advocacy alerts, log in to ASCO.org with your member or guest account, and visit the subscription center available under your account profile.
The American Society of Clinical Oncology has released new tools to help cancer care providers assess and manage age-associated vulnerabilities in older patients undergoing systemic cancer treatment. These tools include a guideline update and new videos on performing a geriatric assessment and using the results to inform patient care.
On July 13, 2023, the Centers for Medicare & Medicaid Services (CMS) released its proposed rule for the 2024 Medicare Physician Fee Schedule (PFS) and updates to the Quality Payment Program (QPP). The agency also released the 2024 Medicare Hospital Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical Center (ASC) Payment System proposed rule.
Cisplatin has been in shortage since February 2023 (per FDA data), and the shortage has grown particularly acute in the last week or two. Accord/Intas released a cisplatin lot this week and subsequent releases are expected.
The American Society of Clinical Oncology (ASCO) is working with eight oncology health systems to develop, test, and measure strategies to improve immunization rates as part of an initiative with the Council of Medical Specialty Societies to improve vaccination rates among high-risk adults.
On January 30, 2023, President Biden announced the COVID-19 Public Health Emergency (PHE) will end on May 11, 2023. This announcement comes after the Department of Health and Human Services (HHS) Secretary Xavier Becerra extended the PHE earlier in January.
What is team-based cancer care and how has it evolved over the past decade? A special series in the American Society of Clinical Oncology’s (ASCO) JCO Oncology Practice highlights transformations in team-based delivery models within the cancer care system and their potential direction.